TO THE SHAREHOLDERS OF EVEREST GROUP, LTD.: The Company's financial statements for the year ended December 31, 2024, together with the report of the Company's auditor in respect of those financial ...
SOUTH SAN FRANCISCO, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill ...
Zevra Continues Growth Trajectory into a Global Commercial Rare Disease Company with Consistent Execution, New Product Launches, and Significant Financial Flexibility to Execute Strategic Plan Urges ...
Outlines Attributes of Carronade’s Four Independent and Highly Qualified Director Nominees and Why They Are Best-Suited to Create Value DARIEN, Conn., April 07, 2025 (GLOBE NEWSWIRE) -- Carronade ...
Proposal 1:To elect the nine directors nominated to the Board of Directors of the Company and named in the Proxy Statement, each for a one-year term ending in 2026. Proposal 2:To approve, by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback